Ketamine, a well-known anaesthetic agent since the 1960s, is now being increasingly recognized for its rapid and robust antidepressant properties — particularly in patients with treatment-resistant depression (TRD) and acute suicidal ideation. While research is still evolving, clinical practice has begun to integrate ketamine therapy in structured, protocol-driven environments.

This article presents an evidence-informed overview of who may benefit from ketamine therapy, who should avoid it, and what constitutes a safe, ethical initiation process.

🧠 What is Ketamine Therapy?

Ketamine is a non-competitive NMDA receptor antagonist. It acts on the glutamatergic system, promoting rapid neuroplastic changes through BDNF (Brain-Derived Neurotrophic Factor) release and mTOR pathway activation (Duman et al., 2012). This action differs fundamentally from traditional monoaminergic antidepressants.

When administered in subanaesthetic doses under supervision, ketamine shows:

• Rapid antidepressant effects within hours

• Improvement in suicidal ideation

• Enhanced emotional connectivity

• Neural rewiring in key mood-regulation regions

✅ Evidence-Based Indications

1. Treatment-Resistant Depression (TRD)

• Defined as failure to respond to two or more antidepressants of adequate dose and duration.

• Multiple RCTs (Zarate et al., 2006; Murrough et al., 2013) have demonstrated a rapid reduction in depressive symptoms within 24 hours.

• Effects last up to 7–14 days post single administration; often used in repeated-dose protocols.

2. Suicidal Ideation

• Ketamine reduces suicidal thoughts independently of its antidepressant effects (Grunebaum et al., 2018).

• Especially useful in emergency settings or while awaiting onset of traditional medications.

• Requires post-session safety planning and follow-up.

3. Post-Traumatic Stress Disorder (PTSD)

• Emerging evidence supports ketamine’s role in trauma memory reconsolidation and emotional blunting (Feder et al., 2014).

• May help with hyperarousal, intrusive thoughts, and emotional numbing when combined with trauma-informed therapy.

4. Obsessive-Compulsive Disorder (OCD)

• A small number of trials show transient benefits in reducing obsessions (Rodriguez et al., 2013).

• Mechanism likely involves enhanced cognitive flexibility via glutamate modulation.

5. Generalized Anxiety Disorder and Social Anxiety

• Patients with refractory anxiety often show coexisting depression or existential distress.

• Ketamine helps reduce rumination and autonomic overactivation (Glue et al., 2020).

6. Chronic Pain Disorders

• CRPS, fibromyalgia, and chronic migraine show benefit from ketamine’s analgesic and anti-inflammatory actions (Sigtermans et al., 2009).

• Often used in interdisciplinary pain clinics.

🧑‍⚕️ Clinical Suitability: Who May Benefit?

The ideal ketamine therapy candidate typically meets the following:

⚠️ When to Avoid or Delay Ketamine Therapy

Absolute Contraindications:

• Schizophrenia or psychotic disorders (risk of exacerbation)

• Uncontrolled hypertension

• History of ketamine misuse or dissociative drug addiction

• Manic episodes in Bipolar I disorder

Relative Contraindications:

• Pregnancy or lactation

• Liver or kidney dysfunction

• Active substance use disorder

• Lack of support system or follow-up care

---

📋 The Evaluation Process

Before initiating therapy, a comprehensive assessment is mandatory:

1. Clinical Interview (ICD/DSM diagnostic confirmation)

2. Treatment History (failed trials, past therapies)

3. Medical Workup (BP, ECG, LFT, RFT)

4. Baseline Psychometrics (PHQ-9, GAD-7, Columbia Suicide Scale)

5. Informed Consent (with documentation of risks, benefits, alternatives)

---

🔄 Dosing and Protocol

While protocols vary, the common formats include:

Therapy is often combined with supportive psychotherapy or CBT-based integration sessions.

---

🔬 What Makes a “Good Responder”?

Patients who:

• Have emotional numbness or anhedonia as core symptoms

• Experience existential distress or trauma-related disconnection

• Are motivated for psychological insight and integration

• Have social support and structured follow-up

---

📘 Final Thoughts

Ketamine is not just a chemical — it’s a catalyst for change, especially when embedded within a safe, supportive, therapeutic alliance.

With appropriate screening, medical oversight, and psychological integration, ketamine-assisted therapy offers a ray of hope for patients who have exhausted traditional options.

---

🧾 References

• Zarate, C. A., et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 63(8), 856–864.

• Murrough, J. W., et al. (2013). Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry, 74(4), 250–256.

• Grunebaum, M. F., et al. (2018). Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry, 175(4), 327–335.

• Feder, A., et al. (2014). Efficacy of intravenous ketamine for treatment of chronic PTSD: a randomized clinical trial. JAMA Psychiatry, 71(6), 681–688.

• Rodriguez, C. I., et al. (2013). Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology, 38(12), 2475–2483.

• Glue, P., et al. (2020). Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. J Psychopharmacol, 34(10), 1083–1090.

• Sigtermans, M., et al. (2009). Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain, 145(3), 304–311.

• Duman, R. S., et al. (2012). Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med, 18(12), 1793–1800.

---

Written by:
Dr. Srinivas Rajkumar T, MBBS, MD (Psychiatry)
Consultant Psychiatrist
Apollo Clinic, Velachery, Chennai
📧 srinivasaiims@gmail.com
📱 +91 85951 55808
🌐 www.srinivasaiims.com

For confidential consultation on whether ketamine-assisted therapy is right for you, reach out for a structured assessment.

---